BOSTON SCIENTIFIC CORP (BSX)

↓ Download CSV

CIK 0000885725 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, BOSTON SCIENTIFIC CORP reported revenue of $20.07B, up 19.9% from the prior year. The company was profitable, with a net margin of 14.4% and a gross margin of 69.0%.

Key ratios (FY2025)

69.0%
Gross margin
18.0%
Operating margin
14.4%
Net margin
11.8%
Return on equity
+19.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$20.07B$16.75B$14.24B$12.68B$11.89B$9.91B$10.73B$9.82B$9.05B$8.39B
Cost of Revenue$6.22B$5.26B$4.34B$3.96B$3.71B$3.46B$3.12B$2.81B$2.59B$2.42B
Gross Profit$13.85B$11.49B$9.90B$8.73B$8.18B$6.45B$7.62B$7.01B$6.46B$5.96B
Operating Income$3.61B$2.60B$2.34B$1.65B$1.20B-$80.00M$1.52B$1.51B$1.28B$447.00M
Net Income$2.89B$1.85B$1.59B$698.00M$1.04B-$82.00M$4.70B$1.67B$104.00M$347.00M
EPS (Diluted)$1.94$1.25$1.07$0.45$0.69$-0.08$3.33$1.19$0.08$0.25
Total Assets$43.67B$39.40B$35.14B$32.47B$32.23B$30.78B$30.57B$21.00B$19.04B$18.10B
Shareholders' Equity$24.47B$22.00B$19.53B$17.57B$16.62B$15.33B$13.88B$8.73B$7.01B$6.73B
Cash & Equivalents$1.97B$414.00M$865.00M$928.00M$1.93B$1.73B$217.00M$146.00M$188.00M$196.00M
Operating Cash Flow$4.53B$3.44B$2.50B$1.53B$1.87B$1.51B$1.84B$310.00M$1.43B$1.18B
Capital Expenditures$876.00M$790.00M$711.00M$588.00M$554.00M$376.00M$461.00M$316.00M$319.00M$376.00M
Shares Outstanding1.49B1.49B1.46B1.44B1.43B1.42B1.41B1.40B1.39B1.38B